We have also found that IL-15-activated PBMCs from AML patients and HDs have a higher capacity to support maturation of DCs than untreated or IL-2 treated PBMCs, suggesting that the increased expression of NKp30 after IL-15 culture improves the capacity of NK cells to collaborate in the maturation of DC. Here, IL2 is linked to acute myeloid leukemia.